Home
/ RNACure
/ Competitors

RNACure Competitors and Similar CompaniesClear all

RNAimmune's competitors and similar companies include Stemirna, Moderna, Mercurna and CureVac.

	RNAimmune RNAimmune is a biotechnology company that focuses on RNA (mRNA) technology	Stemirna Stemirna is an RNA technology-based drug development company.	Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine.	Mercurna Mercurna is a biotech company delivering messenger RNA (mRNA) based medicines.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Founding Date	Founding Date 2020	Founding Date 2016	Founding Date 2010	Founding Date 2017	Founding Date 2000
Type	Type Subsidiary	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech pharma platform	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Germantown, US HQ	Locations Shanghai, CN HQ	Locations Cambridge, US HQ Melbourne, AU Paris, FR München, DE Tokyo, JP Seoul, KR Warszawa, PL see more	Locations HQ	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US
Employees	Employees 128% decrease	Employees N/A	Employees 5,8004% increase	Employees 6	Employees 82517% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 21.2 b	Valuation ($) N/A	Valuation ($) 648.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $1.9b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €535.2m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $868m (FY, 2025)	Cost of goods N/A	Cost of goods €9.7m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $1.1b (FY, 2025)	Gross profit N/A	Gross profit €534.4m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income ($2.8b) (FY, 2025)	Net income N/A	Net income €162.2m (FY, 2024)
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications 2 (May, 2020)	Patent Applications 430 (FY, 2021)	Patent Applications N/A	Patent Applications 500 (Mar, 2020)
Patents Issued	Patents Issued N/A	Patents Issued 2 (May, 2020)	Patents Issued 270 (FY, 2020)	Patents Issued N/A	Patents Issued 233 (May, 2020)
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 188m (almost 5 years ago)	Latest funding round N/A	Latest funding round $ 81.1k (over 7 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 12.4m	Total funding raised $ 206.5m	Total funding raised $ 1.8b	Total funding raised $ 81.1k	Total funding raised $ 1.1b